CBS 2019
CBSMD教育中心
English

急性冠脉综合征

科研文章

荐读文献

Prevalence of Angina Among Primary Care Patients With Coronary Artery Disease Homeostatic Chemokines and Prognosis in Patients With Acute Coronary Syndromes Switching P2Y12-receptor inhibitors in patients with coronary artery disease Long-Term Follow-Up of Complete Versus Lesion-Only Revascularization in STEMI and Multivessel Disease: The CvLPRIT Trial TACIT (High Sensitivity Troponin T Rules Out Acute Cardiac Insufficiency Trial): An Observational Study to Identify Acute Heart Failure Patients at Low Risk for Rehospitalization or Mortality Myocardial Infarction in Young Women Multivessel Versus Culprit-Vessel Percutaneous Coronary Intervention in Cardiogenic Shock An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial Dynamic Myocardial Ultrasound Localization Angiography Predicting Major Adverse Events in Patients With Acute Myocardial Infarction

ConsensusVolume 72, Issue 18, October 2018

JOURNAL:J Am Coll Cardiol. Article Link

Fourth Universal Definition of Myocardial Infarction (2018)

Thygesen K, Alpert JS, Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Keywords: Cardiac procedural myocardial injury; Cardiac troponin; Expert Consensus Document; High sensitivity cardiac troponin; Myocardial infarction; Myocardial infarction with non-obstructive coronary arteries (MINOCA); Myocardial injury; Prior myocardial infarction; Re-infarction; Recurrent myocardial infarction; Silent myocardial infarction; Takotsubo syndrome; Type 1 MI; Type 2 MI; Type 3 MI; Type 4a MI; Type 4b MI; Type 4c MI; Type 5 MI

FULL TEXT PDF